TGFB1 and breast carcinoma: Furthermore, they expand the previously reported ability of CAF‐sEVs to induce TGF‐β signalling activation by establishing their potential to hyperactivate this important pro‐metastatic molecular pathway in breast cancer cells in a paracrine way.